Table 1. Characteristics of radiation oncologists who completed the survey.
| Characteristics | No. respondents [%] |
|---|---|
| Clinical experience | |
| In residency | 24 [12] |
| Specialist (less than 10 years work experience) | 51 [25] |
| Specialist (more than 10 years work experience) | 126 [62] |
| Patients with stage III NSCLC treated per year by the respondent | |
| <5 | 33 [16] |
| 5–15 | 93 [46] |
| >15 | 75 [37] |
| Practise setting | |
| Private practise | 90 [44] |
| General hospital | 45 [22] |
| University hospital | 59 [29] |
| Others | 7 [3] |
| Patients treated with durvalumab after CRT in stage III NSCLC | |
| Yes | 143 [70] |
| No | 60 [30] |
CRT, chemoradiotherapy; NSCLC, non-small cell lung cancer.